From Globenewswire: 2024-04-05 16:30:00

ORIC Pharmaceuticals, Inc. granted 84,800 non-qualified stock options and 14,400 restricted stock units to two new non-executive employees on April 1, 2024. The grants are subject to continued employment and will vest over time. These grants were approved by ORIC’s Compensation Committee and are considered material inducements to employment. ORIC Pharmaceuticals focuses on developing treatments to address therapeutic resistance in cancer, including product candidates like ORIC-114, ORIC-944, and ORIC-533. The company operates in South San Francisco and San Diego, California. For more information, visit their website.



Read more at Globenewswire: ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq